news roundup
ICON's acquisition of Clinical Research Management, Inc. (ClinicalRM), a provider of full service and functional research solutions to U.S. government agencies, extends its presence for government-sponsored research.
Validic's 2016 Global Pharma and Biotech Survey on Digital Health indicates that pharma and biotech are expected to increasingly use digital health tools over the next five years.
advertisment
Click here to watch a short video about Covance's Xcellerate Forecasting & Site Selection tool, which helps forecast study timelines and supports selection of optimal investigator sites.
|
Oncology-drug focused Polaris Pharma has selected Medidata Payments to streamline its clinical trial site reimbursement process.
Updated people moves and business recognition for September.
In our latest poll, 54% of you said a clinical trial was a service, while 20% of you said it was neither. What is a clinical trial?
|
|
|
advertisment
Regulatory Changes in India and What It Means for Clinical Research in the Country Live Webinar: Wednesday, October 19 at 11:00am EDT
Register now
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
advertisment
Simplifying the complexities of global rare disease drug development On-Demand
Learn more
|
|
Articles
Digital platforms have the potential to facilitate clinical trials in underserved populations where lack of infrastructure has made traditional research models unfeasible.
advertisment
Read this interview with IBM company (eClinical Division), discusses risk-based monitoring (RBM) and how the company is innovating a 25-year-old manual process to enable better monitoring decisions. learn More
|
We conducted an investigation specifically to identify and describe the basic requirements for technology solutions, as well as the factors considered by successful lean outsourcers in selecting and implementing the right solutions for their companies. |
|
advertisment
Drive better outcomes with improved trial design Live Webinar: Tuesday, December 6 at 11am EST
Register now
|
Blog Posts
A series of Congressional and FDA rulings led industry to conclude, incorrectly, that efficacy trials in pediatric patients were required in order to incorporate a claim for pediatric use into product labeling.
UCLA knew that its trials were being affected by payment issues, but wanted to examine whether or not the mechanism for patient reimbursement impacted patient retention. |
|
Regulatory
The Healthcare Professionals' Working Party (HCPWP) of the European Medicines Agency (EMA) has re-elected Dr. Gonzalo Calvo as its co-chair.
advertisment
Optimizing real-world evidence programs to generate value Tailored approaches for emerging biopharma On-Demand
Learn more
|
The Regulatory Affairs Professionals Society (RAPS) released its biennial survey, the 2016 Scope of Practice & Compensation Report for the Regulatory Profession, featuring results from 3,358 regulatory professionals in 56 countries.
According to an EMA statement issued in early July in response to the “Brexit” vote, "The implications for the seat and operations of EMA depend on the future relationship between the U.K. and the EU."
Nearly one year has passed since the CFDA was pushed to accelerate its activities to promulgate new or updated regulations and guidelines. This article examines the progress on reforms to date.
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|